Claraphi Advisory Network, LLC Vertex Pharmaceuticals Inc Transaction History

Claraphi Advisory Network, LLC

  • $248 Million
  • Q4 2022

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
SELL
$273.83 - $305.53 $299,570 - $334,249
-1,094 Reduced 58.66%
771 $223,000
Q2 2022

Jul 19, 2022
BUY
$234.96 - $292.55 $438,200 - $545,605
1,865 New
1,865 $526,000
Q2 2020

Aug 14, 2020
SELL
$225.48 - $295.8 $324,916 - $426,247
-1,441 Closed
0 $0
Q1 2020

May 15, 2020
BUY
$199.77 - $247.81 $287,868 - $357,094
1,441 New
1,441 $343,000

Others Institutions Holding VRTX

# of Institutions
1,708
Shares Held
220M
Call Options Held
1.58M
Put Options Held
1.36M
View Full List

About VERTEX PHARMACEUTICALS INC

VRTX Quotes by TradingView
  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $113B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Claraphi Advisory Network, LLC Portfolio

Follow Claraphi Advisory Network, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Claraphi Advisory Network, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Claraphi Advisory Network, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email